Cardio-ankle vascular index value in dyslipidemia patients affected by cardiovascular risk factors

XiaoXiao Zhao1, Liujin Bo1, Hongwei Zhao1

  • 1a Department of Vascular Medicine , Peking University Shougang Hospital , Beijing , China.

Insights

Hypertension significantly increases arterial stiffness in patients with dyslipidemia, as measured by the Cardio-Ankle Vascular Index (CAVI). Diabetes mellitus and smoking did not show a significant impact on CAVI in this study group.

Area of Science:

  • Cardiovascular Medicine
  • Vascular Biology
  • Biomarkers of Atherosclerosis

Background:

  • Arterial stiffness, assessed by Cardio-Ankle Vascular Index (CAVI), is a key cardiovascular risk factor.
  • Dyslipidemia (DLP) is a major contributor to atherosclerosis.
  • The influence of hypertension, diabetes mellitus, and smoking on atherosclerosis in DLP patients requires further investigation.

Purpose of the Study:

  • To investigate the impact of hypertension, diabetes mellitus, and smoking on arterial stiffness (CAVI) in patients with dyslipidemia (DLP).

Main Methods:

  • A cohort of 649 DLP patients (median age 66 years) underwent assessment of fasting plasma glucose, lipid profiles, and CAVI measurement.
  • Blood parameters were analyzed using automated enzymatic assays.
  • CAVI was measured using the VS-1000 apparatus.

Main Results:

  • CAVI showed significant correlations with age, systolic blood pressure, total cholesterol, LDL-cholesterol, and triglycerides.
  • No significant difference in CAVI was observed between smokers and non-smokers, or between statin-treated and non-statin-treated subjects.
  • CAVI was significantly higher in hypertensive and diabetic subjects compared to their respective control groups; however, age-adjusted CAVI remained significantly higher only in the hypertensive group.

Conclusions:

  • Arterial stiffness (CAVI) in DLP patients is significantly increased by hypertension.
  • Diabetes mellitus and smoking do not significantly affect CAVI in patients with dyslipidemia.
  • Hypertension is a critical factor influencing arterial stiffness in individuals with dyslipidemia.
Abstract

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
477
Assessment of the Cardiovascular System III: Palpation01:27

Assessment of the Cardiovascular System III: Palpation

Palpation involves feeling the body to evaluate texture, size, consistency, and tenderness for assessing cardiovascular health. The following steps are organized in a head-to-toe order:
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
1.2K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
592
Cardiovascular System Abnormal Findings I: Inspection and Palpation01:29

Cardiovascular System Abnormal Findings I: Inspection and Palpation

In a cardiovascular examination, inspection and palpation are crucial for identifying abnormalities.
Abnormal findings observed during an inspection
973
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
659
Assessment of the Cardiovascular System II: Inspection01:29

Assessment of the Cardiovascular System II: Inspection

Inspection is the initial step in assessing the cardiovascular system. It involves a detailed visual examination that provides crucial information about a patient's circulatory and cardiac health. This systematic process, conducted from head to toe, helps identify signs of cardiovascular conditions by observing physical appearance, skin and mucous membranes, jugular and carotid pulsations, chest symmetry, and the condition of the extremities.
Head and Neck
937